Floatz logo

PROPOFOL

Monitored Anesthesia Care

Kasr El Aini HospitalSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Monitored Anesthesia Care cohort.

Same molecule, other indications

PROPOFOL is also rated in:

Pain, ChronicDormant
BBB
Indicative ·
79 / 100
View asset →
headache disorderDormant
BBB
Indicative ·
73 / 100
View asset →
morbid obesityDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →